[Featured Stock] JinMatrix Rises for Second Day as Nasdaq Listing of Stakeholder 'Baeksitek' Advances

[Asia Economy Reporter Park Jihwan] Jin Matrix is showing a strong performance for the second consecutive day following the previous day's limit-up, after the news of the Nasdaq listing of the UK vaccine developer Vaxcyte on the 9th.

As of 10:06 AM on this day, Jin Matrix recorded 14,950 won, up 850 won (6.03%) compared to the previous day. On the previous day, it closed at 14,100 won after rising to the price limit. The news of Vaxcyte, which holds about a 5% stake, listing on Nasdaq acted as a positive factor.

According to major foreign media, Vaxcyte is currently pursuing a Nasdaq listing. Vaxcyte is a vaccine developer spun off from the University of Oxford in the UK. Jin Matrix invested 4 million pounds (approximately 6.1 billion won) in Vaxcyte in 2018.